Lan Chen Selected Research

Lan Chen Research Topics

Disease

56	Neoplasms (Cancer) 04/2024 - 01/2002
19	Infections 04/2024 - 11/2008
13	Inflammation (Inflammations) 11/2023 - 11/2002
12	Hypertension (High Blood Pressure) 12/2023 - 02/2005
11	COVID-19 02/2024 - 01/2020
8	Stroke (Strokes) 01/2023 - 08/2015
7	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 09/2006
6	Melanoma (Melanoma, Malignant) 01/2021 - 02/2014
6	Prion Diseases (Transmissible Spongiform Encephalopathies) 09/2007 - 08/2005
5	Parkinson Disease (Parkinson's Disease) 04/2024 - 02/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 08/2005
5	Breast Neoplasms (Breast Cancer) 12/2023 - 02/2012
5	Neoplasm Metastasis (Metastasis) 12/2023 - 08/2017
5	Fibrosis (Cirrhosis) 01/2023 - 06/2019
5	Ischemic Stroke 01/2023 - 07/2017
5	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 07/2016
5	Body Weight (Weight, Body) 11/2022 - 10/2012
5	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 09/2003
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 09/2006
4	Acute Kidney Injury (Acute Renal Failure) 12/2024 - 01/2022
4	Communicable Diseases (Infectious Diseases) 04/2024 - 06/2005
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2023 - 12/2012
4	Squamous Cell Carcinoma of Head and Neck 10/2023 - 01/2020
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 06/2017
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2022 - 10/2017
4	Scrapie 09/2007 - 03/2004
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 01/2015
3	Dementia (Dementias) 10/2023 - 01/2023
3	Hypoxia (Hypoxemia) 10/2023 - 12/2020
3	Insulin Resistance 01/2023 - 10/2012
3	Lung Neoplasms (Lung Cancer) 01/2023 - 02/2004
3	Colitis 01/2023 - 01/2013
3	Adenocarcinoma 01/2023 - 01/2002
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 11/2021
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 03/2005
3	Necrosis 01/2022 - 01/2017
3	Liver Cirrhosis (Hepatic Cirrhosis) 05/2021 - 02/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2018
3	Endometrial Neoplasms (Endometrial Cancer) 11/2018 - 01/2015
3	Prostatic Neoplasms (Prostate Cancer) 08/2006 - 12/2003
2	Asthma (Bronchial Asthma) 04/2024 - 01/2021
2	Diabetes Complications 10/2023 - 10/2022
2	Critical Illness (Critically Ill) 10/2023 - 12/2022
2	Cough 01/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2006
12	VaccinesIBA 01/2024 - 11/2007
11	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 02/2005
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2019
8	AntigensIBA 02/2024 - 05/2009
8	DNA (Deoxyribonucleic Acid)IBA 05/2016 - 12/2003
6	Messenger RNA (mRNA)IBA 12/2022 - 01/2013
6	SaltsIBA 02/2022 - 12/2006
5	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2017
4	AntibodiesIBA 04/2024 - 01/2022
4	LipidsIBA 12/2023 - 01/2020
4	CytokinesIBA 11/2023 - 09/2011
4	Air Pollutants (Pollutants, Air)IBA 11/2023 - 04/2022
4	entinostat (MS 275)IBA 10/2023 - 04/2013
4	EnzymesIBA 10/2023 - 06/2004
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2019
4	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2013
3	Immunoglobulin G (IgG)IBA 04/2024 - 01/2022
3	RNA (Ribonucleic Acid)IBA 12/2023 - 11/2021
3	InterferonsIBA 12/2023 - 01/2023
3	EpitopesIBA 12/2023 - 10/2021
3	Particulate MatterIBA 11/2023 - 01/2022
3	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2022
3	Histone Deacetylase InhibitorsIBA 10/2023 - 04/2013
3	Interleukin-17 (Interleukin 17)IBA 10/2023 - 01/2021
3	Peptides (Polypeptides)IBA 10/2023 - 01/2011
3	Sulfonic AcidsIBA 01/2023 - 01/2013
3	Circular RNAIBA 01/2023 - 01/2020
3	sym-trinitrobenzeneIBA 01/2023 - 01/2013
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 02/2005
3	Neoplasm Antigens (Tumor Antigens)IBA 10/2022 - 04/2013
3	Complement C3 (C3 Complement)IBA 01/2022 - 12/2018
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2019
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2020 - 12/2006
3	oxidized low density lipoproteinIBA 01/2020 - 02/2005
3	Amyloid (Amyloid Fibrils)IBA 04/2014 - 01/2011
3	HDL CholesterolIBA 12/2005 - 02/2005
2	OzoneIBA 04/2024 - 04/2022
2	BilirubinIBA 03/2024 - 03/2016
2	Neutralizing AntibodiesIBA 03/2024 - 01/2012
2	Nylons (Nylon)IBA 01/2024 - 01/2022
2	CollagenIBA 12/2023 - 11/2020
2	Inactivated VaccinesIBA 12/2023 - 12/2023
2	AcidsIBA 10/2023 - 02/2022
2	Agammaglobulinaemia Tyrosine KinaseIBA 07/2023 - 01/2022
2	Chimeric Antigen ReceptorsIBA 07/2023 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2023 - 12/2020

Therapy/Procedure

29	Therapeutics 04/2024 - 07/2007
10	Immunotherapy 10/2023 - 03/2013
5	Drug Therapy (Chemotherapy) 12/2023 - 01/2002
4	Radiotherapy 01/2023 - 01/2002
4	Extracorporeal Membrane Oxygenation 06/2022 - 04/2015
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 01/2019
3	Activities of Daily Living (ADL) 01/2023 - 01/2022
2	Aftercare (After-Treatment) 01/2024 - 01/2022
2	Photothermal Therapy 12/2023 - 10/2023